 |
Anthony Ratcliffe, PhD
Synthasome, Inc |
Anthony Ratcliffe, PhD, is President and CEO of Synthasome, Inc., a biotechnology company in San Diego specializing in orthobiologics. Dr. Ratcliffe obtained his BSc in biochemistry in 1977, and PhD in immunology in 1980, from the University of Birmingham, United Kingdom. He then joined The Kennedy Institute for Rheumatology, London, as a Research Scientist, and in 1987 he moved to Columbia University, New York, as Associate Professor of Orthopaedic Biochemistry. In 1996, he joined Advanced Tissue Sciences (then a leading tissue engineering company), where he served as Vice President for Research until 2002, when he founded Synthasome. Dr. Ratcliffe has focused his research on connective tissue biochemistry, musculoskeletal research, and tissue engineering. He has served as a member of the Board of Directors of the Orthopaedic Research Society, Study Sections for NIH, Co-Chairman of the Grant Review Committee for the Orthopaedic Research and Education Foundation, and Co-Chairman of the Tissue Engineering Committee for ASTM. He is a Fellow of the American Institute of Medical and Biological Engineering and has published more than 100 papers.